Effects of IMB-model-based pharmacist intervention on the compliance and clinical effect on type 2 diabetes with overweight/obesity
Objective To study the effects of pharmacist interventions dominated by information-motivation-behavioral(IMB)model on the compliance and clinical effect in patients suffering from type 2 diabetes(T2DM)with overweight/obesity.Methods T2DM patients with concurrent overweight/obesity who seek treatment in the endocrinology department were enrolled as the research subjects.Single factor analysis and multivariate analysis were used to assess the factors affecting the compliance.The patients were divided into a test group and a control group randomly.The control group was treated with normal procedure.In addition to the routine treatment,the test group was treated with pharmacist intervention measures based on IMB model for 12 months.The indicators of weight,waist circumference(WC),medication compliance,glycosylated hemoglobin(HbA1c),systolic blood pressure(SBP),diastolic blood pressure(DBP),total cholesterol(TC),triglycerides(TG),high density lipoprotein cholesterol(HDL-CH)and low density lipoprotein cholesterol(LDL-CH)in the 2 groups were compared before and after the intervention.Results Totally 96 patients with T2DM with overweight/obesity were included.Patients with good medication compliance reached up to 46.88%.The education level,average monthly family income and frequency of follow-up visits were positively correlated with the patient compliance.After 12 months of pharmacist intervention,the weight,WC,the score of medication compliance scale,the SBP,DBP,HbA1c and blood lipid of patients in the test group were significantly higher than those in the control group(P＜0.05).Conclusion Pharmacist intervention measures based on the IMB model is helpful to improve the weight,WC,blood glucose,blood pressure and blood lipid compliance of T2DM with overweight/obesity,and improve the medication compliance of patients.
万方数据
维普
